The association between the CHEK2 and breast cancer risk in Chinese women is unknown. Here, we screened the full CHEK2 coding sequence in 118 Chinese familial breast cancer cases who are negative for mutations in BRCA1 and BRCA2, one recurrent mutation, CHEK2 c.1111C4T (p.H371Y), was identified in f
Missense mutations (p.H371Y, p.D438Y) in gene CHEK2 are associated with breast cancer risk in women of Balochistan origin
β Scribed by Baloch, Abdul Hameed; Daud, Shakeela; Raheem, Nafeesa; Luqman, Muhammad; Ahmad, Adeel; Rehman, Abdul; Shuja, Jameela; Rasheed, Saeeda; Ali, Akhtar; Kakar, Naseebullah; Naseeb, Hafiz Khush; Mengal, Mohammad Alam; Awan, Muhammad Arif; Wasim, Muhammad; Baloch, Dost Mohammad; Ahmad, Jamil
- Book ID
- 121566126
- Publisher
- Springer
- Year
- 2014
- Tongue
- English
- Weight
- 249 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0301-4851
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Germline mutations in __CHEK2__ have been associated with a range of cancer types but little is known about disease risks conveyed by __CHEK2__ mutations outside of the context of breast and prostate cancer. To investigate whether __CHEK2__ mutations confer an increased risk of bladder
## Abstract p21^Cip1^ and p27^Kip1^ are cyclinβdependent kinase inhibitors, which can arrest cell proliferation and serve as tumor suppressors. Reduced protein expression of p21^Cip1^ and p27^Kip1^ was frequently observed in a subset of cancers, including breast cancer. In this study, we hypothesiz